Bolt Biotherapeutics, Inc. (BOLT) vs Curanex Pharmaceuticals Inc Common Stock (CURX)
A side-by-side comparison of Bolt Biotherapeutics, Inc. and Curanex Pharmaceuticals Inc Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLT
Bolt Biotherapeutics, Inc.
$3.50HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
CURX
Curanex Pharmaceuticals Inc Common Stock
$4.96HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — BOLT vs CURX
growth of $100 · dividends reinvested · last 1yBOLT -35.7% (-35.7%/yr)CURX -93.8% (-93.8%/yr)BOLT compounded faster over this window
Log scale — wide-divergence pair
BOLT CURX
BOLT vs CURX: by the numbers
- •CURX is the larger company ($7M vs $7M market cap).
- •Both run net losses; CURX's is the smaller (0.00% vs -611.47% net margin).
Metrics side by side
Valuation
| Metric | BOLT | CURX |
|---|---|---|
| P/S ratio | 1.43 | N/A |
| P/B ratio | 0.53 | 1.47 |
Profitability
| Metric | BOLT | CURX |
|---|---|---|
| Gross margin | 80.62% | 0.00% |
| Operating margin | -450.07% | 0.00% |
| Net margin | -611.47% | 0.00% |
| ROE | -227.37% | -218.65% |
| ROIC | -90.17% | -208.39% |
Growth (annualized)
| Metric | BOLT | CURX |
|---|---|---|
| Total return CAGR (5Y) | -57.61% | N/A |
Go deeper
Dig into the metrics
Bolt Biotherapeutics ROECuranex Pharmaceuticals Inc Common Stock ROEBolt Biotherapeutics operating marginCuranex Pharmaceuticals Inc Common Stock operating marginBolt Biotherapeutics revenue growthCuranex Pharmaceuticals Inc Common Stock revenue growthBolt Biotherapeutics free cash flowCuranex Pharmaceuticals Inc Common Stock free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.